Provided by Tiger Trade Technology Pte. Ltd.

Pyxis Oncology, Inc.

1.99
-0.0200-1.00%
Post-market: 1.990.0038+0.19%19:30 EDT
Volume:1.10M
Turnover:2.14M
Market Cap:236.98M
PE:-1.42
High:2.03
Open:2.03
Low:1.90
Close:2.01
52wk High:5.55
52wk Low:1.03
Shares:119.08M
Float Shares:108.42M
Volume Ratio:0.65
T/O Rate:1.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4029
EPS(LYR):-1.2813
ROE:-179.10%
ROA:-62.95%
PB:20.71
PE(LYR):-1.55

Loading ...

Pyxis Oncology Prices Unregistered Private Placement at USD 50 Million

Reuters
·
Jul 03

Pyxis Oncology is Maintained at Outperform by Leerink Partners

Dow Jones
·
Jul 02

Pyxis Oncology Posts Corporate Deck Outlining Strategy to Build Differentiated Antibody-drug Conjugate Company Around MICVO Program in Head and Neck Cancer

Reuters
·
Jun 30

Pyxis Oncology announces up to $114M private placement

TIPRANKS
·
Jun 30

Guggenheim Sticks to Its Buy Rating for Pyxis Oncology (PYXS)

TIPRANKS
·
Jun 30

Pyxis Oncology Prices USD 50 Million Private Placement at USD 2.55 a Share

Reuters
·
Jun 30

Pyxis Oncology - Expects Updated Phase 1 Monotherapy Data in Fall 2026 and Phase 1/2 Data in Q4 2026

THOMSON REUTERS
·
Jun 30

Pyxis Oncology - Sells 19.6 Mln Shares at $2.55 Each with Warrants at $3.29 Exercise Price

THOMSON REUTERS
·
Jun 30

Pyxis Oncology: Financing Led by Bvf Partners L.p. with Participation from Gordonmd Global Investments, Rtw Investments, & Coastlands Capital

THOMSON REUTERS
·
Jun 30

Pyxis Oncology - Upfront Proceeds Expected to Extend Cash Runway into Q2 2027

THOMSON REUTERS
·
Jun 30

Pyxis Oncology Announces up to $114 Million Private Placement Financing to Advance Micvo Through Key Clinical Milestones

THOMSON REUTERS
·
Jun 30

Pyxis Oncology Announces Up to $114 Million Private Placement Financing to Advance MICVO Through Key Clinical Milestones

GlobeNewswire
·
Jun 30

Penny Stocks To Watch For Growth In June 2026

Simply Wall St.
·
Jun 19

Pyxis Oncology Stockholders Approve Directors and Auditor Slate

TIPRANKS
·
Jun 16

Pyxis Oncology holds annual shareholder meeting via webcast

Reuters
·
Jun 16

Pyxis Oncology (PYXS) Gets a Buy from LifeSci Capital

TIPRANKS
·
May 23

Analysts Offer Insights on Healthcare Companies: Pyxis Oncology (PYXS) and Actuate Therapeutics, Inc. (ACTU)

TIPRANKS
·
May 18

Analysts Conflicted on These Healthcare Names: Aquestive Therapeutics (AQST), Pyxis Oncology (PYXS) and Biogen (BIIB)

TIPRANKS
·
May 15

RBC Capital Keeps Their Buy Rating on Pyxis Oncology (PYXS)

TIPRANKS
·
May 15

Pyxis Oncology (PYXS) Gets a Buy from Guggenheim

TIPRANKS
·
May 15